Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Medina Keita

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Neurodegenerative Disease Management|June 29, 2022
Friedreich ataxia: clinical features and new developmentsMedina Keita, Kellie McIntyre, Layne N Rodden, et al.
Neurology and Therapy|April 30, 2025
Safety Monitoring of Omaveloxolone in Friedreich Ataxia: Results from One Year of Clinical TreatmentKatherine Gunther, Victoria Profeta, Medina Keita, et al.
Journal of Neurology|December 8, 2023
Frataxin analysis using triple quadrupole mass spectrometry: application to a large heterogeneous clinical cohortDavid R Lynch, Teerapat Rojsajjakul, S H Subramony, et al.
Annals of Clinical and Translational Neurology|June 19, 2023
Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxiaLayne N Rodden, Kellie McIntyre, Medina Keita, et al.
Journal of the Neurological Sciences|May 17, 2024
Characterization of clinical serum cardiac biomarker levels in individuals with Friedreich ataxiaDavid R Lynch, Sonal Sharma, Patrick Hearle, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Neurodegenerative Disease Management|June 29, 2022
Friedreich ataxia: clinical features and new developmentsMedina Keita, Kellie McIntyre, Layne N Rodden, et al.
Neurology and Therapy|April 30, 2025
Safety Monitoring of Omaveloxolone in Friedreich Ataxia: Results from One Year of Clinical TreatmentKatherine Gunther, Victoria Profeta, Medina Keita, et al.
Journal of Neurology|December 8, 2023
Frataxin analysis using triple quadrupole mass spectrometry: application to a large heterogeneous clinical cohortDavid R Lynch, Teerapat Rojsajjakul, S H Subramony, et al.
Annals of Clinical and Translational Neurology|June 19, 2023
Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxiaLayne N Rodden, Kellie McIntyre, Medina Keita, et al.
Journal of the Neurological Sciences|May 17, 2024
Characterization of clinical serum cardiac biomarker levels in individuals with Friedreich ataxiaDavid R Lynch, Sonal Sharma, Patrick Hearle, et al.
Pageof 1